Navigation Links
Pharmasset Announces Proposed Public Offering of Common Stock
Date:1/18/2011

PRINCETON, N.J., Jan. 18, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today that it has commenced an underwritten public offering, subject to market and other conditions, of 3,000,000 shares of its common stock pursuant to an effective shelf registration statement.  Of the shares being sold, Pharmasset is selling 2,000,000 shares and the selling stockholders are selling 1,000,000 shares.  Pharmasset intends to grant to the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock. Citi is serving as sole book-running manager and Morgan Stanley is serving as co-lead manager for the offering.

Pharmasset intends to use the net proceeds from the sale of the shares by Pharmasset for general corporate purposes, which may include, but are not limited to, the funding of clinical trials, the funding of in-licensing agreements for product candidates, the funding of additional technologies or other forms of intellectual property and the acquisition of assets or businesses that are complementary to its existing business.

The shares described above are being offered by Pharmasset and the selling stockholders pursuant to an automatic shelf registration statement filed earlier today with the Securities and Exchange Commission, which became effective immediately upon filing.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the prospectus supplement and accompanying base prospectus relating to this offering may be obtained from Citi at Brooklyn Army Terminal, 140 58th Street, 8th Floor,
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Reports Positive Results from its HCV Clinical Programs
2. Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial of PSI-7977 for Chronic Hepatitis C
4. Pharmasset to Webcast an Investor Event from the AASLD Meeting
5. Pharmasset to Present at the JMP Healthcare Conference
6. Pharmasset to Present at the UBS Global Life Sciences Conference
7. Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3
8. Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
9. Pharmasset Reports Fiscal Year End 2009 Financial Results
10. Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
11. Pharmasset to Present at Lazard Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015   Generational Equity , a leading ... pleased to announce the acquisition of its client, ... Spokane, Washington , by Mi-Med Supply , ... 30, 2015. Peaks & Plains is ... selling medical, incontinent, nutritional, patient care, and housekeeping equipment ...
(Date:5/26/2015)... Ore. , May 26, 2015 ... rehabilitation business solutions, today announced the results of ... practices perform day-to-day activities. 759 therapists, practice owners ... confirmed a widespread industry need for technology and ... response to the survey findings, Clinicient published a ...
(Date:5/26/2015)... 2015  PAREXEL International Corporation (NASDAQ: PRXL ) ... Goldman Sachs Healthcare Conference in Palos Verdes, CA.  ... will be making a presentation on PAREXEL and discussing ... 9, 2015. A live webcast of the ... PAREXEL,s website at www.PAREXEL.com in the Upcoming ...
Breaking Medicine Technology:Generational Equity Announces the Acquisition of Peaks & Plains Inc. by Mi-Med Supply 2Survey: Half of Physical Therapists Underbill For Their Services 2PAREXEL International To Present At Goldman Sachs Healthcare Conference 2
... Somatropin Formulation Demonstrate Advantages ... Over Existing Once-Daily Product, ... UK-based speciality pharmaceuticals,company, today announced that the successful completion ... synthetic human growth,hormone (hGH) somatropin. Trials demonstrated therapeutic plasma,concentrations ...
... DIEGO, Sept. 30 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ... JMP,Securities 3rd Annual Healthcare Focus Conference on Tuesday, October ... conference is being held at Le,Parker Meridien in New ... Executive Officer of Anadys,will present an overview of Anadys ...
Cached Medicine Technology:Critical Pharmaceuticals Enter Sustained Release hGH Arena 2Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference 2
(Date:5/26/2015)... Rochester, MN (PRWEB) May 26, 2015 ... years of debilitating nosebleeds and fainting spells, four of ... even leading to cardiac arrest. , Though she ... transfusion, she continues to dedicate her time to increasing ... mission. , “Had there been awareness, we could have ...
(Date:5/26/2015)... May 26, 2015 The American College of ... them for the Open House/Free Application Day on Wednesday, July ... until 4 p.m. and will be held at ACTCM Pioneer ... , After checking in, attendees will be greeted with an ... tour of the campus at 11:45 a.m. Lunch will be ...
(Date:5/26/2015)... May 26, 2015 Abington is ... Wellness, a physician practice with seven medical professionals, ... the eighth primary-care site in the United States ... medical home by the National Committee for Quality ... primary, preventative and sick care – including routine ...
(Date:5/26/2015)... 2015 It was an evening befitting ... Colorado. On Wednesday, May 13, The Denver Foundation marked ... era of community-based giving with its Annual Celebration, held ... the Making,” the event celebrated the donors, leaders, grantees, ... mobilize resources for good. , “If your organization, neighborhood ...
(Date:5/26/2015)... 26, 2015 Allprovide, the all-natural raw ... all-natural dog foods are now available in three Georgia ... and The Good Old Dog Company in Kennesaw. , ... recently opened a state-of-the-art, climate controlled facility. The fresh ... and all of the food is triple-tested for quality. ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:ACTCM to Host Summer Open House 2Health News:Family Medicine, Geriatrics and Wellness Joins Abington Health Physicians 2Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Allprovide, the All-Natural Pet Food, Available At Georgia Retailers 2
... New research at Oregon State University provides evidence for the ... "clocks" found in many animals can clearly cause accelerated ... study was published in Neurobiology of Disease and ... University. Prior to this, it wasn,t clear which came first ...
... 10, 2012) According to the results of a ... the Journal of the American College of Surgeons ... their disease and were not meaningfully involved in treatment ... treatment. As a result, the study,s investigators determined that ...
... TUESDAY, Jan. 10 (HealthDay News) -- A drug commonly used ... be effective for people older than 40 years who have ... Although previous animal studies of the Alzheimer,s drug, ... new study of people with Down syndrome aged 40 and ...
... issue of Annals takes an up-close look at ... single individual, a phenomenon that is growing at an alarming ... estimated by the year 2020, 25 percent of the American ... for managing these conditions will reach $1.07 trillion. In fact, ...
... has severe consequences, with a 25 to 80 percent risk ... AKI using a urine test, enabling emergency departments to identify ... The study will be published online on January 9, 2012, ... Physicians typically measure a patient,s creatinine levels to ...
... HealthDay Reporter , MONDAY, Jan. 9 (HealthDay News) ... suggests new research that finds losing a loved one can ... of a significant other,s death, heart attack risk was 21 ... on nearly 2,000 heart attack patients. And within the first ...
Cached Medicine News:Health News:Disruption of biological clocks causes neurodegeneration, early death 2Health News:Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer 2Health News:Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer 3Health News:Alzheimer's Med Seems Ineffective in Those With Down Syndrome 2Health News:January/February 2012 Annals of Family Medicine 2Health News:January/February 2012 Annals of Family Medicine 3Health News:January/February 2012 Annals of Family Medicine 4Health News:January/February 2012 Annals of Family Medicine 5Health News:January/February 2012 Annals of Family Medicine 6Health News:January/February 2012 Annals of Family Medicine 7Health News:January/February 2012 Annals of Family Medicine 8Health News:January/February 2012 Annals of Family Medicine 9Health News:Biomarkers identify acute kidney injury in emergency patients 2Health News:Grief Is a Real Heartbreaker, Study Finds 2Health News:Grief Is a Real Heartbreaker, Study Finds 3
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack....
... hydrophilic acrylic IOL is the newest advance ... with the patient and surgeon in mind. ... optic polymerically crosslinked with PMMA haptics to ... excellent visual performance and biocompatibility. The high ...
Raysoft Foldable Intraocular Lens....
BIGBAG Hydrophilic Acrylic Lens for high myopia....
Medicine Products: